Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The approved GLP-1 class medications as of 2025 include semaglutide (Wegovy for obesity, Ozempic for type 2 diabetes), tirzepatide (Zepbound for obesity, Mounjaro for type 2 diabetes), and oral semaglutide (Rybelsus, now in a higher-dose formulation as Wegovy oral)
We can get in front of chronic disease and reach people before metabolic disorder takes root
LBA 45 Lapauw, B
See our full insurance list here
CUSTOMER REVIEWS What researchers say Loading reviews QUESTIONS Frequently Asked About RETATRUTIDE YOU MAY ALSO LIKE Related research compounds RETATRUTIDE 10MG A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models
US$ 26.83
US$ 25.71
US$ 29.36
US$ 27.75
US$ 25.11
US$ 28.73
US$ 22.68
